Da. Pearce et al., Phenotypic reversal of the btn1 defects in yeast by chloroquine: A yeast model for Batten disease, P NAS US, 96(20), 1999, pp. 11341-11345
Citations number
43
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
BTN1 of Saccharomyces cerevisiae encodes an ortholog of CLN3, the human Bat
ten disease gene. We have reported previously that deletion of BTN1, btn1-D
elta, resulted in a pH-dependent resistance to D-(-)-threo-2-amino-1-[p-nit
rophenyl]-1,3-propanediol (ANP). This phenotype was caused by btn1-Delta st
rains having an elevated ability to acidify growth medium through an elevat
ed activity of the plasma membrane H+-ATPase, resulting from a decreased va
cuolar pH during early growth. We have determined that growing btn1-Delta s
trains in the presence of chloroquine reverses the resistance to ANP, decre
ases the rate of medium acidification, decreases the activity of plasma mem
brane H+-ATPase, and elevates vacuolar pH. However, an additional effect of
this phenotypic reversal is that activity of plasma membrane H+-ATPase is
decreased further and vacuolar pH is increased further as btn1-Delta strain
s continue to grow. This phenotypic reversal of btn1-Delta can be considere
d for developing a therapy far Batten disease.